State of Alaska Department of Revenue’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
33,314
+2,717
| +9% | +$85.6K | 0.01% | 1024 |
|
|
2025
Q1 | $1M | Sell |
30,597
-786
| -3% | -$25.7K | 0.01% | 1012 |
|
|
2024
Q4 | $1.13M | Sell |
31,383
-73
| -0.2% | -$2.64K | 0.01% | 991 |
|
|
2024
Q3 | $980K | Sell |
31,456
-857
| -3% | -$26.7K | 0.01% | 1078 |
|
|
2024
Q2 | $864K | Sell |
32,313
-969
| -3% | -$25.9K | 0.01% | 1083 |
|
|
2024
Q1 | $1.14M | Sell |
33,282
-329
| -1% | -$11.2K | 0.01% | 967 |
|
|
2023
Q4 | $972K | Sell |
33,611
-380
| -1% | -$11K | 0.01% | 1017 |
|
|
2023
Q3 | $937K | Sell |
33,991
-1,853
| -5% | -$51.1K | 0.01% | 987 |
|
|
2023
Q2 | $1.08M | Sell |
35,844
-1,174
| -3% | -$35.3K | 0.01% | 935 |
|
|
2023
Q1 | $1.34M | Sell |
37,018
-624
| -2% | -$22.6K | 0.02% | 834 |
|
|
2022
Q4 | $1.34M | Buy |
37,642
+572
| +2% | +$20.4K | 0.02% | 811 |
|
|
2022
Q3 | $1.25M | Sell |
37,070
-3,331
| -8% | -$113K | 0.02% | 809 |
|
|
2022
Q2 | $1.17M | Buy |
40,401
+3,405
| +9% | +$98.4K | 0.01% | 873 |
|
|
2022
Q1 | $1.2M | Sell |
36,996
-660
| -2% | -$21.3K | 0.01% | 910 |
|
|
2021
Q4 | $1.1M | Sell |
37,656
-1,115
| -3% | -$32.5K | 0.01% | 1032 |
|
|
2021
Q3 | $1.03M | Buy |
38,771
+2,077
| +6% | +$55.4K | 0.01% | 1066 |
|
|
2021
Q2 | $1.13M | Buy |
36,694
+870
| +2% | +$26.8K | 0.01% | 1007 |
|
|
2021
Q1 | $937K | Sell |
35,824
-5,180
| -13% | -$135K | 0.01% | 1090 |
|
|
2020
Q4 | $1.03M | Sell |
41,004
-8,268
| -17% | -$208K | 0.01% | 948 |
|
|
2020
Q3 | $1.03M | Sell |
49,272
-290
| -0.6% | -$6.04K | 0.01% | 871 |
|
|
2020
Q2 | $1.18M | Buy |
49,562
+3,010
| +6% | +$71.5K | 0.02% | 785 |
|
|
2020
Q1 | $837K | Buy |
46,552
+6,935
| +18% | +$125K | 0.01% | 846 |
|
|
2019
Q4 | $939K | Sell |
39,617
-675
| -2% | -$16K | 0.01% | 946 |
|
|
2019
Q3 | $1.11M | Buy |
40,292
+22,461
| +126% | +$617K | 0.02% | 807 |
|
|
2019
Q2 | $590K | Buy |
17,831
+195
| +1% | +$6.45K | 0.01% | 976 |
|
|
2019
Q1 | $617K | Buy |
17,636
+130
| +0.7% | +$4.55K | 0.01% | 945 |
|
|
2018
Q4 | $581K | Buy |
17,506
+447
| +3% | +$14.8K | 0.01% | 897 |
|
|
2018
Q3 | $858K | Buy |
17,059
+120
| +0.7% | +$6.04K | 0.01% | 806 |
|
|
2018
Q2 | $1.01M | Buy |
16,939
+300
| +2% | +$17.9K | 0.02% | 701 |
|
|
2018
Q1 | $762K | Buy |
16,639
+6,430
| +63% | +$294K | 0.02% | 755 |
|
|
2017
Q4 | $406K | Buy |
10,209
+240
| +2% | +$9.55K | 0.01% | 882 |
|
|
2017
Q3 | $398K | Buy |
9,969
+40
| +0.4% | +$1.6K | 0.02% | 761 |
|
|
2017
Q2 | $427K | Buy |
9,929
+4,399
| +80% | +$189K | 0.03% | 490 |
|
|
2017
Q1 | $173K | Buy |
5,530
+170
| +3% | +$5.32K | 0.01% | 734 |
|
|
2016
Q4 | $135K | Buy |
+5,360
| New | +$135K | 0.01% | 554 |
|